These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29993146)

  • 1. Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial.
    Nicklas C; Rubio R; Cárdenas C; Hasson A
    Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):3-10. PubMed ID: 29993146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study.
    Serini SM; Cannizzaro MV; Dattola A; Garofalo V; Del Duca E; Ventura A; Milani M; Campione E; Bianchi L
    J Cosmet Dermatol; 2019 Feb; 18(1):156-162. PubMed ID: 29790262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle.
    Cunliffe WJ; Meynadier J; Alirezai M; George SA; Coutts I; Roseeuw DI; Hachem JP; Briantais P; Sidou F; Soto P
    J Am Acad Dermatol; 2003 Sep; 49(3 Suppl):S218-26. PubMed ID: 12963898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.
    Thiboutot DM; Shalita AR; Yamauchi PS; Dawson C; Arsonnaud S; Kang S;
    Skinmed; 2005; 4(3):138-46. PubMed ID: 15891249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
    Keating GM
    Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.
    Thiboutot DM; Shalita AR; Yamauchi PS; Dawson C; Kerrouche N; Arsonnaud S; Kang S
    Arch Dermatol; 2006 May; 142(5):597-602. PubMed ID: 16702497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin.
    Del Rosso JQ; Stein Gold L; Johnson SM; Rueda MJ; Baldwin H; Lain EL; Landis M; Rendon M; Tanghetti E; Weiss J
    J Drugs Dermatol; 2018 Mar; 17(3):264-273. PubMed ID: 29537444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
    Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
    Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
    Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
    Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study.
    Hörfelt C; Funk J; Frohm-Nilsson M; Wiegleb Edström D; Wennberg AM
    Br J Dermatol; 2006 Sep; 155(3):608-13. PubMed ID: 16911289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
    Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
    J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
    Pariser DM; Eichenfield LF; Bukhalo M; Waterman G; Jarratt M;
    Br J Dermatol; 2016 Apr; 174(4):770-7. PubMed ID: 26663215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose topical 5-aminolevulinic acid photodynamic therapy in the treatment of different severity of acne vulgaris.
    Ma L; Xiang LH; Yu B; Yin R; Chen L; Wu Y; Tan ZJ; Liu YB; Tian HQ; Li HZ; Lin T; Wang XL; Li YH; Wang WZ; Yang HL; Lai W
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):583-90. PubMed ID: 24284115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate.
    Wiegell SR; Wulf HC
    J Am Acad Dermatol; 2006 Apr; 54(4):647-51. PubMed ID: 16546587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin.
    Tan J; Humphrey S; Vender R; Barankin B; Gooderham M; Kerrouche N; Audibert F; Lynde C;
    Br J Dermatol; 2014 Dec; 171(6):1508-16. PubMed ID: 24934963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter randomized controlled trial on combination therapy with 0.1% adapalene gel and oral antibiotics for acne vulgaris: comparison of the efficacy of adapalene gel alone and in combination with oral faropenem.
    Hayashi N; Kawashima M
    J Dermatol; 2012 Jun; 39(6):511-5. PubMed ID: 22168326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for severe facial acne vulgaris with 5% 5-aminolevulinic acid vs 10% 5-aminolevulinic acid: A split-face randomized controlled study.
    Zhang J; Zhang X; He Y; Wu X; Huang J; Huang H; Lu C
    J Cosmet Dermatol; 2020 Feb; 19(2):368-374. PubMed ID: 31187937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
    Thiboutot D; Arsonnaud S; Soto P
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
    Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
    J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.